Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
07/14/1992 | CA1305057C Calcium salts |
07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
07/09/1992 | WO1992011269A1 Novel methylenebisphosphonic acid derivatives |
07/09/1992 | WO1992011267A1 Novel methylenebisphosphonic acid derivatives |
07/08/1992 | EP0448704A4 Osteogenic devices |
07/08/1992 | EP0202282B1 New use of 1,4-dihydropyridine derivatives |
07/08/1992 | CN1062534A Methylenebisphosphonic acid derivatives |
07/08/1992 | CN1062533A Methylenebisphosphonic acid derivatives |
07/08/1992 | CN1062532A Methylenebisphosphonic acid derivatives |
06/25/1992 | WO1992010511A1 Compounds and compositions which inhibit bone resorption |
06/25/1992 | WO1992009586A1 Active oxygen inhibitor |
06/21/1992 | WO1992011268A1 Novel methylenebisphosphonic acid derivatives |
06/21/1992 | CA2098734A1 Novel mrthylenebisphosphonic acid derivatives |
06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
06/11/1992 | WO1992009697A1 USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-β FOR BONE REPAIR |
06/11/1992 | WO1992009304A1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
06/02/1992 | US5118667 Bone growth factors and inhibitors of bone resorption for promoting bone formation |
05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
05/26/1992 | US5116828 Pharmaceutical composition for treatment of osteoporosis |
05/26/1992 | US5116573 Labelled vitamin d3 derivative and production process thereof |
05/22/1992 | WO1992009203A1 Tnf inhibitors |
05/22/1992 | CA2096623A1 Tnf inhibitors |
05/20/1992 | WO1992008985A2 Ligand-mediated immunofunctional hormone binding protein assay method |
05/20/1992 | EP0486022A2 Naphthalene derivatives |
05/17/1992 | CA2055630A1 Naphthalene derivatives |
05/14/1992 | WO1992007578A1 Use of protective agents against reactive oxygen species |
05/14/1992 | WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140 |
05/12/1992 | US5112867 Triphenylmethane derivatives |
05/12/1992 | US5112866 Sulfonylfluorides as intermediates, also useful in treatment of bone disorders, antisecretory, antiulcer |
05/05/1992 | CA1300017C Composition for preventing osteoporosis |
04/30/1992 | WO1992007073A1 Osteogenic peptides |
04/15/1992 | EP0480659A2 Use of Angiotensin-II antagonists for the manufacture of a medicament for the treatment of hyperuricemia |
04/01/1992 | EP0477885A2 Parathyroid hormone derivatives |
03/25/1992 | EP0476646A1 Calcium uptake inhibitors |
03/25/1992 | EP0476045A1 Bioerodible polymers for drug delivery in bone. |
03/19/1992 | WO1992005187A1 NEW 17-β-OESTRADIOL DERIVATIVES, A METHOD OF PREPARING THEM, AND DRUGS CONTAINING THEM |
03/19/1992 | DE4029499A1 Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel New 17- (beta) -oestradiolderivate, process for their production and pharmaceutical compositions containing them |
03/19/1992 | CA2091268A1 17-.beta.-oestradiol derivatives, processes for their preparation and medicaments containing these compounds |
03/18/1992 | EP0474712A1 Lysolecithin derivatives for treating autoimmune diseases. |
03/11/1992 | EP0474374A1 Method for treatment of bone wasting diseases using a progestin |
03/08/1992 | WO1992004310A1 Triarylethylene carboxylic acids with estrogenic activity |
03/08/1992 | CA2089373A1 Triarylethylene carboxylic acids with estrogenic activity |
03/04/1992 | CN1059143A Pyrazolopyridine compound and process for prepn. thereof |
02/18/1992 | US5089492 Pharmaceuticals and dietetics containing acylamino acid derivatives |
02/11/1992 | CA2048810A1 Method for treatment of bone wasting diseases |
02/07/1992 | WO1992002235A1 Calcium and trace mineral supplements |
02/06/1992 | WO1992001718A2 Functionally active selectin-derived peptides and ligand for gmp-140 |
02/05/1992 | EP0469837A2 Use of a compound in the manufactur of a medicament for lowering of blood uric acid levels |
01/28/1992 | US5084450 Progestomimetic and antiesterogenic steroids for animals |
01/22/1992 | EP0467248A2 Pyrazolopyridine compound and processes for preparation thereof |
01/08/1992 | EP0464946A1 5-Isothiazolamine derivates |
01/08/1992 | EP0464509A1 Biphosphonic acid derivatives, their production and use |
01/07/1992 | US5079261 Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
01/04/1992 | CA2045003A1 5-isothiazolamine derivatives |
01/02/1992 | EP0463004A1 Metabolic effects of leukaemia inhibitory factor on bone |
12/31/1991 | CA1293727C 9-deazaguanines |
12/26/1991 | WO1991019510A1 Osteoinductive pharmaceutical formulations |
12/26/1991 | CA2045293A1 Bisphosphonic acid derivatives, their production and use |
12/18/1991 | EP0461218A1 Oxypurinol salt composition for oral administration for treating hyperurecemia. |
12/17/1991 | US5073562 Antiinflammatory agents; leukotriene by antagonists |
12/12/1991 | WO1991018622A1 Wound healing |
12/12/1991 | WO1991018594A1 The pharmacological use of certain cystine derivatives |
12/11/1991 | EP0460690A2 Use of phenolsulfophthaline derivatives for the treatment of osteoporosis |
12/11/1991 | EP0460488A1 Sulfur-containing heterocyclic compounds |
12/11/1991 | EP0460205A1 Radiolabeled colloid compositions, their use and process for their preparation |
12/10/1991 | US5072042 Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom |
12/10/1991 | US5071841 Sulfur-containing heterocyclic compounds useful for the treatment of osteoporosis, and their production |
12/01/1991 | CA2043468A1 Sulfur-containing heterocyclic compounds |
11/28/1991 | WO1991018098A1 Bone and cartilage inductive proteins |
11/28/1991 | WO1991018089A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
11/28/1991 | CA2082941A1 Bone and cartilage inductive proteins |
11/27/1991 | EP0458640A2 Use of ergoline derivatives for the treatment of diseases associated with bone demineralization |
11/27/1991 | CN1014891B Process for preparation of di-tert-butyl phenol compounds |
11/26/1991 | CA2042960A1 Method of inhibiting demineralization of bone |
11/21/1991 | EP0457381A2 Delta 2-cephem sulphones |
11/20/1991 | CN1014787B Phenoxyacetic acid derivative and processes for preparing same |
11/17/1991 | WO1991017989A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof |
11/17/1991 | CA2083040A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof |
11/12/1991 | US5064830 Lowering of blood uric acid levels |
11/11/1991 | WO1991017160A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof |
11/11/1991 | CA2082500A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof |
11/06/1991 | EP0455503A1 Composition for treating osteoporosis and hormonal imbalance |
11/05/1991 | US5063234 Method of inhibiting demineralization of bone |
11/05/1991 | CA2041799A1 Composition for treating osteoporosis and hormonal imbalance |
10/29/1991 | US5061476 Radiolabeled colloid compositions and method for preparing same |
10/15/1991 | CA1290691C Methods of treating bone diseases by administration of a cysteine proteinase inhibitor |
10/03/1991 | WO1991014785A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
10/03/1991 | CA2039458A1 Methods for treating interleukin-1 mediated diseases |
10/02/1991 | EP0449764A2 A method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptor antagonist |
10/02/1991 | EP0449079A2 Hydantoin derivative |
10/02/1991 | EP0448704A1 Osteogenic devices |
10/01/1991 | CA1289878C Composition for stimulating chondrocytes and osteoblasts (osseinhydroxyapatite compound), method for its production and pharmaceutical products containing said composition |
09/25/1991 | EP0448253A2 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
09/24/1991 | US5051438 Treating leukotriene by mediated diseases; antiinflammatory agents |
09/24/1991 | US5051424 Piperazine compounds which act as sedatives or antidepressants |
09/10/1991 | US5047554 3-substituted-2-oxindole derivatives |
09/10/1991 | CA1288695C Method for increasing bone mass |
09/03/1991 | CA1288424C Inclusion complex of 7-isopropoxy-isoflavon formed with cyclodextrin, the preparation thereof and pharmaceutical compositions containing these compounds as active ingredient |
08/28/1991 | EP0444000A2 Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture |